Galderma Investigational Site 8618
Waco, Texas 76710-4023
1 studies enrolling now · 3 studies all time
What they study most
Atopic Dermatitis, Moderate-to-Severe Atopic Dermatitis
Studies at this site
- Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Recruiting now
- Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
- Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed